378 related articles for article (PubMed ID: 22123355)
1. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
Kaloyannidis P; Mallouri D
Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
[TBL] [Abstract][Full Text] [Related]
2. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
Greinix HT; Tanew A
Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
[TBL] [Abstract][Full Text] [Related]
3. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
Komanduri KV; Couriel D; Champlin RE
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis in children with graft-versus-host disease.
Chan KW
J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
[TBL] [Abstract][Full Text] [Related]
8. Nonpharmacologic treatment of chronic graft-versus-host disease in children and adolescents.
Lawitschka A; Ball L; Peters C
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S74-81. PubMed ID: 22226116
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
Greinix HT; Worel N; Just U; Knobler R
Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
13. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
Marshall SR
Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis in chronic graft-versus-host disease.
Foss FM; Gorgun G; Miller KB
Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
[TBL] [Abstract][Full Text] [Related]
15. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
Woltz P; Castro K; Park BJ
Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
18. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children.
Goussetis E; Varela I; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):203-9. PubMed ID: 22079263
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
20. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
Greinix HT; Knobler RM; Worel N; Schneider B; Schneeberger A; Hoecker P; Mitterbauer M; Rabitsch W; Schulenburg A; Kalhs P
Haematologica; 2006 Mar; 91(3):405-8. PubMed ID: 16531267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]